These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Successful long-term management of refractory cutaneous and upper airway sarcoidosis with periodic infliximab infusion.
    Author: Rosen T, Doherty C.
    Journal: Dermatol Online J; 2007 Jul 13; 13(3):14. PubMed ID: 18328208.
    Abstract:
    A clinically refractory case of cutaneous sarcoidosis was successfully treated with infliximab infusion therapy at a dose of 5mg/kg. Skin lesions cleared dramatically and remain resolved during a 3(1/2) year follow-up, the longest follow-up reported to date. Ongoing biological drug therapy has been administered at a frequency of every 8-10 weeks. Despite cost and safety concerns, infliximab should be considered in cases of cutaneous sarcoidosis refractory to standard treatment protocols.
    [Abstract] [Full Text] [Related] [New Search]